Diagnosis, treatment and outcome of congenital hypothyroidism

Area of Science:

• Pediatrics
• Endocrinology
• Neonatal Care

Background:

• Congenital hypothyroidism (CH) screening in newborns is vital.
• Elevated thyroid-stimulating hormone (TSH) necessitates further evaluation.
• Early diagnosis and treatment prevent irreversible neurological damage.

Purpose of the Study:

• To outline the diagnostic and management pathway for newborns with elevated TSH.
• To emphasize the importance of timely intervention and monitoring in CH.
• To discuss long-term outcomes and specific considerations for patient populations.

Main Methods:

• Initial screening for elevated TSH.
• Confirmation of hypothyroidism via serum TSH and thyroxine (T4) levels.
• Etiological investigation using sodium pertechnetate scintigraphy.
• Prompt initiation of levothyroxine treatment.
• Regular clinical and biochemical monitoring during the first three years.
• Assessment of hypothyroidism permanence after age three by temporarily withholding treatment.
• Documentation of growth, psychomotor development, and school progression.

Main Results:

• Screening and prompt treatment significantly improve cognitive outcomes.
• Frequent monitoring is critical during early childhood to prevent brain damage.
• Long-term follow-up is necessary to confirm hypothyroidism permanence, except in specific cases.
• Transition to adult care and pregnancy counseling are important for females.

Conclusions:

• Newborn screening for congenital hypothyroidism is highly effective.
• Timely diagnosis and adequate levothyroxine treatment are paramount for neurodevelopmental outcomes.
• Continued monitoring and specialized care are essential throughout childhood and into adulthood.